Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35302663.
- Also identified by DOI 10.1002/cncr.34168 and PMC identifier 9543969.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.
Medical subject headings
- Circulating Tumor DNA
- Neoplasms
- Neoplasms, Second Primary